17-HYDROXY-19-NORPREGNA-4,9,11-TRIEN-20-YN-3-ONE OXIME, (17.ALPHA.)-
UNII H9HF9HFB24

Substance Identification & Data

This profile provides standardized clinical and technical data for 17-hydroxy-19-norpregna-4,9,11-trien-20-yn-3-one Oxime, (17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H9HF9HFB24.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 19636-23-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H9HF9HFB24

CAS Registry Number

19636-23-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

17-HYDROXY-19-NORPREGNA-4,9,11-TRIEN-20-YN-3-ONE OXIME, (17.ALPHA.)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H23NO2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SBDCBFADDSQCBB-FYQPLNBISA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

131875577

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1C(C=C2C(C1)=C3[C@@](CC2)([C@]4([C@](C=C3)([C@](CC4)(O)C#C)C)[H])[H])=NO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 17-hydroxy-19-norpregna-4,9,11-trien-20-yn-3-one Oxime, (17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.